Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,527,409
-
Share change
-
-3,162,128
-
Total reported value
-
$19,493,252
-
Price per share
-
$0.79
-
Number of holders
-
41
-
Value change
-
-$4,194,254
-
Number of buys
-
10
-
Number of sells
-
24
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q2 2022
As of 30 Jun 2022,
RECRO PHARMA INC - COM (SCTL) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,527,409 shares.
The largest 10 holders included
AWM Investment Company, Inc., Cowen Prime Advisors LLC, Samjo Capital LLC, Athyrium Capital Management, LP, VANGUARD GROUP INC, Rubric Capital Management LP, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, STEPHENS INC /AR/, and First Eagle Investment Management, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.